国内首个脑转移瘤精准放疗IIT研究启动

Core Viewpoint - The first Investigator Initiated Trial (IIT) for precision radiotherapy of brain metastases in China has been successfully launched, focusing on the clinical efficacy and safety of the ZAP-X radiosurgery robot in patients with brain tumors [1] Group 1: Clinical Research - The IIT is a collaboration between Xuanwu Hospital and Baiyang Pharmaceutical (301015.SZ) [1] - The principal investigator (PI) of the study is Zhang Hongqi, the director of the neurosurgery department at Xuanwu Hospital [1] - The study aims to explore the dosimetric characteristics and clinical outcomes of the ZAP-X system in treating brain metastases [1]